Bioneer Corporation (KQ:064550) — Market Cap & Net Worth
Market Cap & Net Worth: Bioneer Corporation (064550)
Bioneer Corporation (KQ:064550) has a market capitalization of $117.11 Million (₩172.80 Billion) as of October 16, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18584 globally and #867 in its home market, demonstrating a -8.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioneer Corporation's stock price ₩7820.00 by its total outstanding shares 22097400 (22.10 Million).
Bioneer Corporation Market Cap History: 2015 to 2026
Bioneer Corporation's market capitalization history from 2015 to 2026. Data shows change from $137.48 Million to $117.11 Million (-1.18% CAGR). Check Bioneer Corporation share price for real-time trading data and today's change.
Index Memberships
Bioneer Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$237.32 Billion | 0.05% | #337 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$237.32 Billion | 0.05% | #337 of 1384 |
Weight: Bioneer Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bioneer Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioneer Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash flow conversion of Bioneer Corporation for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.00x
Bioneer Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $137.48 Million | $20.83 Billion | -$5.37 Billion | 0.01x | N/A |
| 2016 | $102.66 Million | $21.70 Billion | -$14.42 Billion | 0.00x | N/A |
| 2017 | $134.78 Million | $23.27 Billion | -$9.87 Billion | 0.01x | N/A |
| 2018 | $111.26 Million | $24.08 Billion | -$8.82 Billion | 0.00x | N/A |
| 2019 | $101.68 Million | $36.29 Billion | -$7.83 Billion | 0.00x | N/A |
| 2020 | $265.81 Million | $206.99 Billion | $57.90 Billion | 0.00x | 0.00x |
| 2021 | $727.79 Million | $223.74 Billion | $27.16 Billion | 0.00x | 0.03x |
| 2022 | $440.27 Million | $218.39 Billion | $12.08 Billion | 0.00x | 0.04x |
| 2023 | $498.67 Million | $263.24 Billion | -$10.59 Billion | 0.00x | N/A |
| 2024 | $282.28 Million | $293.98 Billion | -$20.58 Billion | 0.00x | N/A |
Competitor Companies of 064550 by Market Capitalization
Companies near Bioneer Corporation in the global market cap rankings as of October 16, 2026. See net asset quality index of Bioneer Corporation to understand what proportion of total assets are financed by equity.
Key companies related to Bioneer Corporation by market ranking:
- Peptron Inc (KQ:087010): Ranked #9124 globally with a market cap of $928.56 Million USD ( ₩1.37 Trillion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19321 globally with a market cap of $97.35 Million USD ( ₩143.65 Billion KRW).
- Cell Biotech Co. Ltd (KQ:049960): Ranked #20117 globally with a market cap of $79.00 Million USD ( ₩116.57 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #20228 globally with a market cap of $76.74 Million USD ( ₩113.24 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #9124 | Peptron Inc | KQ:087010 | $928.56 Million | ₩89400.00 |
| #19321 | MEDIPOST Co. Ltd | KQ:078160 | $97.35 Million | ₩9340.00 |
| #20117 | Cell Biotech Co. Ltd | KQ:049960 | $79.00 Million | ₩15100.00 |
| #20228 | Macrogen Inc | KQ:038290 | $76.74 Million | ₩11300.00 |
Bioneer Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Bioneer Corporation's market cap moved from $137.48 Million to $ 117.11 Million, with a yearly change of -1.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩117.11 Million | -38.67% |
| 2025 | ₩190.93 Million | -32.36% |
| 2024 | ₩282.28 Million | -43.39% |
| 2023 | ₩498.67 Million | +13.27% |
| 2022 | ₩440.27 Million | -39.51% |
| 2021 | ₩727.79 Million | +173.80% |
| 2020 | ₩265.81 Million | +161.41% |
| 2019 | ₩101.68 Million | -8.61% |
| 2018 | ₩111.26 Million | -17.44% |
| 2017 | ₩134.78 Million | +31.29% |
| 2016 | ₩102.66 Million | -25.33% |
| 2015 | ₩137.48 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 15th, 2026 the market cap of Bioneer Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $117.11 Million USD |
| MoneyControl | $117.11 Million USD |
| MarketWatch | $117.11 Million USD |
| marketcap.company | $117.11 Million USD |
| Reuters | $117.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bioneer Corporation
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analys… Read more